Beta Drugs Ltd share price logo

Beta Drugs Ltd

NSE: BETA

Small Cap

Pharma Sector

₹1871.00

-10.60

(-0.56%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with Beta Drugs shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

+271%

Searches for Beta Drugs on INDmoney have increased by 271% over the last 30 days.

Investment activity on INDmoney

+340.00%

Investment activity in Beta Drugs among INDmoney users has increased by 340.00% over the last 30 days.

Average holding period of indmoney investors

14 days

INDmoney investors hold Beta Drugs shares for an average of 14 days.

Beta Drugs Stock Performance

as on November 11, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹1,850.80
    ₹1,902.00
    downward going graph

    1.08%

    Downside

    1.66%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹990.10
    ₹2,807.90
    downward going graph

    47.08%

    Downside

    50.07%

    Upside

    downward going graph

Beta Drugs share price movements today

Previous Close
₹1,881.60
Open
₹1,900.00
Volume
13.07K
Upper Circuit
₹2,257.90
Lower Circuit
₹1,505.30
Day's Low - High
₹1,850.80 - ₹1,902.00
52 Week Low - High
₹990.10 - ₹2,807.90

Beta Drugs Historical Returns

1 Month Return
+ 2.02 %
3 Month Return
-29.48 %
1 Year Return
+ 12.37 %
3 Year Return
+ 70.21 %
5 Year Return
+ 246.58 %

Beta Drugs Fundamentals

as on November 11, 2026 at 4:01 pm IST

Market Cap

₹2,092.58 Cr

Return on Equity (ROE)

10.29

PE Ratio (TTM)

38.64

Return on capital employed (ROCE)

10.94

Industry PE ratio

55.07

Beta (LTM)

0.85

P/B Ratio

8.06

Dividend Yield

0

PEG Ratio

6.13

Quarterly Earnings Growth YOY

57.77

EPS (TTM)

40.92

Book Value

241.46

Beta Drugs Stock Valuation

as on November 11, 2026 at 4:01 pm IST

Beta Drugs in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 29, 2025

Today (38.64x)

November 9, 2026

Industry (55.07x)

November 9, 2026

Highest (60.36x)

August 11, 2026

LowHigh

Today’s Price to Earnings Ratio: 38.64x

Beta Drugs Technical Analysis

Track how Beta Drugs technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bearish

Overall

Bearish2
Bullish10
Neutral3

Oscillators

Name

Value

Action

MACD level (12,26)
3
Bullish
CCI (20)
107.07
Bearish
RSI (14)
68.53
Neutral
Momentum (10)
9.3
Bearish
ADI (14)
14.81
Neutral
Ultimate Oscillator (7,14,28)
55.63
Neutral

Moving Averages

Name

Value

Action

SMA (20)
1871.48
Bullish
EMA (20)
1871.9
Bullish
VWMA (20)
1873.12
Bullish
SMA (50)
1866.37
Bullish
EMA (50)
1868.19
Bullish
SMA (200)
1865.93
Bullish
EMA (200)
1867.28
Bullish
KAMA (200)
1869.44
Bullish
DEMA (200)
1864.5
Bullish

Beta Drugs Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Beta Drugs with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Beta Drugs Ltd image
Beta Drugs Ltd
NA2,092.5849.32%0.7041384
Sat Kartar Life Ltd image
Sat Kartar Life Ltd
NA244.91-0.8%0.5217200
Adline Chem Lab Ltd image
Adline Chem Lab Ltd
NA9.2439.58%0.00-1NA
Sotac Pharmaceuticals Ltd image
Sotac Pharmaceuticals Ltd
NA143.651.53%0.716101
Medico Remedies Ltd image
Medico Remedies Ltd
NA156.67-4.4%0.0013206
See all

Beta Drugs Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Sales
88.29
93.76
100.21
103.39
87.27
93.96
125.55
137.49
Other Income
0.97
3.96
2.99
2.99
2.31
2.89
1.58
1.75
Total Income
89.26
97.73
103.19
106.37
89.58
96.86
127.13
139.24
Expenses
72.18
78.64
80.5
82.08
70.28
76.29
98.18
107.21
Operating Profit
16.11
15.12
19.71
21.31
16.99
17.67
27.37
30.28
Operating Profit Margin %
18.25%
16.13%
19.67%
20.61%
19.47%
18.81%
21.8%
22.02%
Profit Before Interest, Tax and Depreciation
17.07
19.09
22.69
24.3
19.3
20.57
28.95
32.03
Interest
1.88
3.29
3.32
3.61
4.43
3.94
2.56
1.64
Depreciation
3.24
3.57
3.73
4.24
4.39
4.8
4.35
4.61
Profit Before Tax
11.95
12.23
15.64
16.45
10.48
11.83
22.04
25.78
Tax Paid
3.01
3.2
3.95
4.23
1.95
2.78
5.56
6.49
Profit After Tax
8.95
9.03
11.7
12.22
8.52
9.05
16.49
19.28
Total Net profit including share of profit / Loss from associate company
8.95
9.03
11.7
12.22
8.52
9.05
16.49
19.28
EPS
9.31
9.4
11.59
12.1
8.4
8.93
14.78
16.59
Actual EPS
9.31
9.4
11.59
12.1
8.4
8.93
14.78
16.59
Adjusted EPS
9.31
9.4
11.59
12.1
8.4
8.93
14.78
16.59
Diluted EPS
9.31
9.4
11.59
12.1
8.4
8.93
14.78
16.59

Beta Drugs Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
65.93
90.81
116.12
183.84
227.11
295.71
362.36
384.83
Other Income
0.37
0.41
0.5
0.76
0.75
1.36
6.44
11.18
Total Income
66.3
91.22
116.62
184.59
227.87
297.07
368.79
396.01
Expenses
54.12
72.9
91.38
141.14
173.99
235.72
292.32
309.15
Operating Profit
11.81
17.91
24.74
42.7
53.12
59.99
70.04
75.68
Operating Profit Margin %
17.91%
19.72%
21.31%
23.23%
23.39%
20.29%
19.33%
19.67%
Profit Before Interest, Tax and Depreciation
12.18
18.32
25.24
43.45
53.88
61.36
76.47
86.86
Interest
1.43
2.59
2.42
1.9
2.41
2.82
6.99
15.31
Depreciation
2.84
3.76
6.87
7.25
10.41
9.78
12.51
17.15
Profit Before Tax
7.91
11.97
15.95
34.3
41.06
48.76
56.97
54.4
Tax Paid
-0.13
2.56
4.23
9.48
10.34
12.32
14.55
12.91
Profit After Tax
8.04
9.42
11.72
24.83
30.72
36.44
42.42
41.48
Total Net profit including share of profit / Loss from associate company
8.04
9.42
11.72
24.83
30.72
36.44
42.42
41.48
EPS
9.3
9.93
12.2
25.82
31.95
37.9
42.02
40.92
Actual EPS
9.3
9.93
12.2
25.82
31.95
37.9
42.02
40.92
Adjusted EPS
8.86
9.46
11.62
24.59
30.43
36.1
42.02
40.92
Diluted EPS
9.3
9.93
12.2
25.82
31.95
37.9
42.02
40.92

Beta Drugs Ltd Cash Flow

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
17.1
0.11
8.41
18.6
29.63
23.38
30.93
36.14
37.29
Cash Flow from Investing Activities
-10.79
-20.78
-15.06
-5.86
-21.76
-19.07
-13.98
-35.72
-51.39
Cash Flow from Financing Activities
5.45
12.07
8.72
-7.72
-0.98
-2.47
-7.49
117.97
-8.07
Net Cash Flow
11.76
-8.61
2.09
5.04
6.9
1.84
9.47
118.39
-22.18

Beta Drugs Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Nov 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Nov 2025
Dec 2025
Mar 2026
May 2026
Jun 2026
Sep 2026
Promoters
66.73%
66.73%
66.73%
66.73%
66.73%
66.73%
66.73%
66.73%
66.73%
66.73%
64.9%
66.73%
59.1%
59.1%
58.91%
DII
0.02%
0%
0%
0%
0%
0%
0%
0%
0%
0%
1.9%
0.29%
6.01%
6.23%
6.45%
FII
0.32%
0%
0%
0%
0%
0%
0%
0%
0%
0%
1.14%
0.9%
2.95%
1.02%
1.37%
Public
32.92%
32.88%
32.25%
31.95%
31.94%
31.95%
32.2%
32.11%
32.07%
32.08%
32.07%
32.07%
31.93%
33.65%
33.27%
Total Outstanding Shares
96,13,790
96,13,790
96,13,790
96,13,790
96,13,860
96,13,860
1,00,94,553
1,00,94,553
1,00,94,553
1,00,94,553
1,00,94,553
1,00,94,553
1,10,85,872
1,10,85,872
1,11,21,255
Total Shareholders
1,928
2,116
2,323
2,567
2,793
2,882
3,054
3,139
3,184
3,003
3,694
3,184
5,027
7,359
10,145

Beta Drugs Corporate Actions

View detailed summary of the earnings and dividend history of Beta Drugs.

  • Beta Drugs Ltd Earnings Results

    Beta Drugs Ltd’s net profit jumped 51.8% since last year same period to ₹18.55Cr in the Q2 2026-2027. On a quarterly growth basis, Beta Drugs Ltd has generated 17.41% jump in its net profits since last 3-months.

    Read More

Insights on Beta Drugs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 1.02% to 1.37% in Sep 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Laurus Labs Ltd has given 560.9% return, outperforming this stock by 490.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Laurus Labs Ltd has given 149.0% return, outperforming this stock by 136.6%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 33.65% to 33.27% in Sep 2026 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, BETA stock has moved down by -29.5%

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 59.10% to 58.91% in Sep 2026 quarter

About Beta Drugs Ltd

Beta Drugs Limited is a part of the Adley Group, established in 1985 by its promoter Vijay Batra. It is a pharmaceutical formulation manufacturing company that produces and markets drugs to domestic and international customers. The Company specializes in the production of oncology products such as anticancer tablets, capsules, injections and lyophilized injections. With a portfolio of over 50 products catering to various oncology diseases such as breast cancer, brain cancer, bone cancer, lung cancer, mouth cancer, head and neck cancer, prostate cancer, haematology and cervics oeaophagus, Beta Drugs is an important contributor to the healthcare industry. The Company was originally incorporated in Himachal Pradesh in 2005 as a private limited company and was converted into a public limited company in 2017. Under the charge of Vijay Batra, Beta Drugs has become a well-recognized and trusted international healthcare brand.

Revenue: ₹137.49Cr as on September 2026 (Q2 FY27)
Net Profit: ₹19.28Cr as on September 2026 (Q2 FY27)
Listing date: 12 Oct, 2017
Chairperson Name: Rahul Batra
OrganisationBeta Drugs Ltd
IndustryPharmaceuticals
CEORahul Batra
E-voting on sharesClick here to vote

FAQs

What is Beta Drugs share price today?

Beta Drugs share price today stands at ₹1871 as on at the close of the market. Beta Drugs share today touched a day high of ₹1902 and a low of ₹1850.8.

What is the 52 week high and 52 week low range for Beta Drugs share?

Beta Drugs touched a 52 week high of ₹2807.9 and a 52 week low of ₹990.1. Beta Drugs share price today i.e. is closed at ₹1871, which is -33.37% down from its 52 week high and 88.97% up from its 52 week low.

What is Beta Drugs's market capitalisation today?

Beta Drugs market capitalisation is ₹2,092.58 Cr as on .

How to buy Beta Drugs shares?

To buy Beta Drugs shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for BETA or Beta Drugs Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Beta Drugs shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Beta Drugs trading volume today?

Beta Drugs trading volume is 13.07K as on . This means that 13.07K shares of Beta Drugs were bought and sold on the stock market during today's trading session.

What are INDmoney investors doing with Beta Drugs shares right now?

Based on aggregated, anonymised INDmoney platform data, search interest and investment activity in Beta Drugs have both increased over the past 30 days, and the average INDmoney investor holds the stock for 14 days. This reflects platform activity only and is not investment advice.